These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of sudden coronary death by chronic antiarrhythmic therapy. Koch-Weser J Adv Cardiol; 1978; 25():206-28. PubMed ID: 360790 [No Abstract] [Full Text] [Related]
4. Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacing. Rothfeld EL; Zucker IR; Tiu R; Parsonnet V Am J Cardiol; 1970 Jul; 26(1):52-5. PubMed ID: 5427832 [No Abstract] [Full Text] [Related]
6. The role of antiarrhythmic drugs in prevention of sudden cardiac death. Podrid PJ Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903 [No Abstract] [Full Text] [Related]
7. Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction. Chung EK Postgrad Med; 1973 Oct; 54(4):197-203. PubMed ID: 4729173 [No Abstract] [Full Text] [Related]
8. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents. Murnaghan MF Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011 [No Abstract] [Full Text] [Related]
9. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. Anderson JL; Harrison DC; Meffin PJ; Winkle RA Drugs; 1978 Apr; 15(4):271-309. PubMed ID: 648399 [No Abstract] [Full Text] [Related]
10. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Nestico PF; Morganroth J Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of antiarrhythmic drugs. Harrison DC; Meffin PJ; Winkle RA Prog Cardiovasc Dis; 1977; 20(3):217-42. PubMed ID: 335439 [No Abstract] [Full Text] [Related]
12. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894 [TBL] [Abstract][Full Text] [Related]
13. [Tachyarrhythmias caused by acute myocardial infarct]. Popescu PN; Mihail A Med Interna (Bucur); 1970 Dec; 22(12):1443-50. PubMed ID: 4100622 [No Abstract] [Full Text] [Related]
14. Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction. Jewitt DE; Mercer CJ; Hubner PJ; Shillingford JP Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358169 [No Abstract] [Full Text] [Related]
15. Protocol for the management of arrhythmias in acute myocardial infarction. Grace WJ Crit Care Med; 1974; 2(5):235-42. PubMed ID: 4455450 [No Abstract] [Full Text] [Related]
16. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Wyman MG; Hammersmith L Am J Cardiol; 1974 May; 33(5):661-7. PubMed ID: 4820897 [No Abstract] [Full Text] [Related]
17. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome. Forester D Chest; 1979 Jun; 75(6):745. PubMed ID: 436537 [No Abstract] [Full Text] [Related]
18. [Ventricular fibrillation caused by myocardial infarction refractory to electric shock and xylocaine. Positive response to intravenous mexiletine]. Forzoni M; Lucioli F; Burali A Minerva Cardioangiol; 1985 Mar; 33(3):135-9. PubMed ID: 4010980 [No Abstract] [Full Text] [Related]
19. Management of persistently recurring ventricular fibrillation with propranolol hydrochloride. Rothfeld EL; Lipowitz M; Zucker IR; Parsonnet V; Bernstein A JAMA; 1968 May; 204(6):546-8. PubMed ID: 5694440 [No Abstract] [Full Text] [Related]